A new horizon of endoscopic anti-reflux therapy

The new horizon of endoscopic anti-reflux therapy is exemplified by the emergence of Anti-Reflux Mucosal (ARM) interventions, which include anti-reflux mucosectomy (ARMS), mucosal ablation (ARMA), and mucoplasty (ARMP). These techniques represent a groundbreaking advancement in the minimally invasive treatment of gastroesophageal reflux disease (GERD), particularly for patients who remain symptomatic despite pharmacologic therapy. ARM therapies aim to bridge the gap between long-term acid suppression with medications and invasive surgical options like Nissen fundoplication.

Key Features and Innovations in Endoscopic Anti-Reflux Therapy:

1. Rationale for Development:

• GERD is a prevalent condition, and approximately 30–40% of patients continue to experience symptoms despite the use of proton pump inhibitors (PPIs) or potassium-competitive acid blockers (PCABs).
• ARM techniques were developed to provide a cost-effective, incisionless, and minimally invasive alternative for patients with drug-refractory GERD who do not have large hiatal hernias or major esophageal motility disorders.

2. Mechanism of Action:

• ARM procedures rely on mucosal removal or modification to induce ulceration, followed by controlled healing at the gastroesophageal junction (GEJ). This healing process leads to shrinkage and tightening of the GEJ, reconstructing the natural mucosal flap valve and enhancing its anti-reflux barrier function.

3. Specific Techniques:

• Anti-Reflux Mucosectomy (ARMS): Involves mucosal resection to induce controlled scarring and tightening of the GEJ. Long-term data show symptom improvement in 68–81% of patients and PPI discontinuation in 42%.
• Anti-Reflux Mucosal Ablation (ARMA): A simpler variant of ARMS that uses argon plasma coagulation instead of resection. It achieves clinical response rates exceeding 70% with measurable improvements in reflux metrics.
• Anti-Reflux Mucoplasty (ARMP): A more advanced technique that closes mucosal defects during the initial session, providing immediate anti-reflux effects and reducing risks of delayed ulcer healing or bleeding.

4. Technical Innovations:

• Tools such as prong clips, loop-assisted systems, and hand suturing have enabled full-thickness closure, involving mucosa, submucosa, and muscle fibers, to reinforce the anti-reflux flap valve.
• The development of the "angle booster" accessory improves endoscopic access and visualization of the cardia, enhancing procedural precision.
• The counter-mucosal incision technique prevents dehiscence during mucosal closure, ensuring durable valve tightening.

5. Clinical Outcomes:

• ARM interventions have demonstrated success rates of 70–82% in terms of symptom relief and PPI discontinuation.
• Minor complications, such as transient dysphagia (11%) and bleeding (5%), are typically manageable endoscopically, with no major life-threatening complications reported in meta-analyses.

6. Comparative Effectiveness:

• ARM techniques show comparable efficacy to radiofrequency ablation and Nissen fundoplication, with the added benefits of shorter recovery times, reduced postoperative discomfort, and lower costs.
• ARMP provides controlled tightening and immediate symptom relief, making it a preferred option for patients with naïve anatomy, while ARMA is suited for redo cases or patients with submucosal fibrosis.

7. Application Beyond GERD:

• The mucoplasty principle is being explored for other gastrointestinal conditions, such as treating multiple Schatzki’s rings. This represents the first functional "endoscopic plastic surgery" approach in gastrointestinal disease.

8. Future Directions:

• Research is focusing on the long-term durability of ARM techniques, standardization of ulcer dimensions for optimal tightening, incorporation of full-thickness suturing, and cost-effectiveness comparisons with surgical options like Nissen fundoplication and magnetic sphincter augmentation.

Conclusion:

Endoscopic anti-reflux therapy, particularly ARM interventions, has redefined the treatment landscape for GERD. These techniques offer a minimally invasive, anatomy-tailored approach that provides significant symptom relief (70–82%) with minimal complications. By addressing the limitations of pharmacologic therapy and offering an alternative to surgery, ARM therapies represent a promising new horizon in the individualized management of GERD.